469 Cooperation between checkpoint inhibitors targeting the PD-1/PD-L1 axis and ATRC-101, a novel clinical-stage candidate for the treatment of solid tissue malignancies

• Jeff DeFalco,
• Gilson Baia,
• Judevin Lugar-Supagay,
• Ish Dhawan,
• Dai-Chen Wu,
• Carl Millward,
• Jonathan Benjamin

Affiliations

Jeff DeFalco

Aff386 Atreca Redwood City CA USA

Gilson Baia

Aff386 Atreca Redwood City CA USA

Judevin Lugar-Supagay

Atreca Inc., South San Francisco, CA, USA

Ish Dhawan

Atreca Inc., South San Francisco, CA, USA

Dai-Chen Wu

Atreca Inc., South San Francisco, CA, USA

Carl Millward

Atreca Inc., South San Francisco, CA, USA

Jonathan Benjamin

Atreca Inc., South San Francisco, CA, USA